celecoxib has been researched along with Drug Hypersensitivity in 43 studies
Drug Hypersensitivity: Immunologically mediated adverse reactions to medicinal substances used legally or illegally.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A special regulatory role for prostaglandin E2 has been postulated in aspirin-induced asthma." | 9.13 | Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity. ( Cmiel, A; Gawlewicz-Mroczka, A; Gielicz, A; Mastalerz, L; Sanak, M; Szczeklik, A, 2008) |
| "To determine whether celecoxib, a selective cyclooxygenase 2 (COX-2) inhibitor, cross-reacts in patients with aspirin-exacerbated respiratory disease (AERD) with asthma." | 9.10 | The safety of celecoxib in patients with aspirin-sensitive asthma. ( Simon, RA; Stevenson, DD; Woessner, KM, 2002) |
| "Subjects with aspirin-intolerant asthma (AIA) respond with bronchoconstriction and extrapulmonary adverse reactions to conventional nonsteroidal anti-inflammatory drugs (NSAIDs) that inhibit the cyclooxygenase (COX) step in the biosynthesis of prostaglandins." | 9.10 | Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib. ( Bochenek, G; Dahlén, B; Dahlén, SE; Drupka, D; Gyllfors, P; Isakson, PC; Kumlin, M; Lefkowith, JB; Mejza, F; Murray, JJ; Nizankowska, E; Overholt, J; Sheller, J; Szczeklik, A, 2003) |
| "The literature provides information regarding the safety of COX-2 inhibitors in asthma patients with aspirin-exacerbated respiratory disease (AERD)." | 8.82 | Safety of COX-2 inhibitors in asthma patients with aspirin hypersensitivity. ( Fernández, C; West, PM, 2003) |
| "The Fernand Widal syndrome is a set of associations between asthma, nasal polyposis and aspirin sensitivity." | 7.88 | [Is celecoxib a safe alternative for the Fernand Widal syndrome?] ( De Blay, F; Guenard-Bilbaut, L; Metz-Favre, C; Schaller, A, 2018) |
| "Erythema multiforme is an acute inflammatory skin reaction that often is caused by drugs, especially sulfonamides and their derivatives." | 5.31 | Celecoxib-induced erythema multiforme with glyburide cross-reactivity. ( Egge, JA; Ernst, EJ, 2002) |
| "A special regulatory role for prostaglandin E2 has been postulated in aspirin-induced asthma." | 5.13 | Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity. ( Cmiel, A; Gawlewicz-Mroczka, A; Gielicz, A; Mastalerz, L; Sanak, M; Szczeklik, A, 2008) |
| " Three subjects with multiple-drug induced urticaria complained of a generalized reaction after challenge (Two due to celecoxib and one due to meloxicam)." | 5.11 | Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients. ( Antonicelli, L; Bilò, MB; Bonadonna, P; Crivellaro, MA; Dama, AR; Schiappoli, M; Senna, G, 2004) |
| "Patients with NSAID-induced urticaria or angioedema were challenged in a double-masked, placebo-controlled design protocol with etoricoxib (120 mg) and celecoxib (200 mg)." | 5.11 | Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema. ( Caballero-Fonseca, F; Capriles-Hulett, A; Sánchez-Borges, M, 2005) |
| "To determine whether celecoxib, a selective cyclooxygenase 2 (COX-2) inhibitor, cross-reacts in patients with aspirin-exacerbated respiratory disease (AERD) with asthma." | 5.10 | The safety of celecoxib in patients with aspirin-sensitive asthma. ( Simon, RA; Stevenson, DD; Woessner, KM, 2002) |
| "Subjects with aspirin-intolerant asthma (AIA) respond with bronchoconstriction and extrapulmonary adverse reactions to conventional nonsteroidal anti-inflammatory drugs (NSAIDs) that inhibit the cyclooxygenase (COX) step in the biosynthesis of prostaglandins." | 5.10 | Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib. ( Bochenek, G; Dahlén, B; Dahlén, SE; Drupka, D; Gyllfors, P; Isakson, PC; Kumlin, M; Lefkowith, JB; Mejza, F; Murray, JJ; Nizankowska, E; Overholt, J; Sheller, J; Szczeklik, A, 2003) |
| "Nonsteroidal anti-inflammatory drugs (NSAIDs) cause bronchospasm in susceptible patients with asthma, often termed aspirin-exacerbated respiratory disease (AERD), with the risk being greatest after acute exposure." | 4.90 | Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials. ( Donnan, PT; Guthrie, B; Jackson, C; Lipworth, BJ; Morales, DR; Santiago, VH, 2014) |
| "The literature provides information regarding the safety of COX-2 inhibitors in asthma patients with aspirin-exacerbated respiratory disease (AERD)." | 4.82 | Safety of COX-2 inhibitors in asthma patients with aspirin hypersensitivity. ( Fernández, C; West, PM, 2003) |
| "The Fernand Widal syndrome is a set of associations between asthma, nasal polyposis and aspirin sensitivity." | 3.88 | [Is celecoxib a safe alternative for the Fernand Widal syndrome?] ( De Blay, F; Guenard-Bilbaut, L; Metz-Favre, C; Schaller, A, 2018) |
| " Here, we report on celecoxib desensitization after a celecoxib-induced skin reaction, thereby allowing the continuation of temozolomide/celecoxib chemotherapy in a young patient with recurrent astrocytoma." | 3.78 | Celecoxib desensitization: continued temozolomide/celecoxib chemotherapy after a celecoxib-induced hypersensitivity reaction. ( Burbach, GJ; Vajkoczy, P; Zuberbier, T, 2012) |
| " Four additional DILI cases were identified after LY3031207 dosing had been stopped." | 2.87 | Dose-dependent acute liver injury with hypersensitivity features in humans due to a novel microsomal prostaglandin E synthase 1 inhibitor. ( Campanale, K; Hall, DG; Henck, J; Hu, L; Jin, Y; Kam, J; Landschulz, W; McNearney, TA; Nakano, M; Phipps, K; Regev, A; Smith, C; Uetrecht, J; Yang, XY, 2018) |
| " Phone call follow up in 25 patients disclosed that 15 patients continued to take celecoxib, while five patients did not take celecoxib following the oral challenge, and five discontinued celecoxib due to adverse effects, lack of drug efficacy or physician preference." | 2.71 | Safety of celecoxib in individuals allergic to sulfonamide: a pilot study. ( Knowles, SR; Neuman, MG; Shapiro, LE; Shear, NH; Weber, E, 2003) |
| "Adverse reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) are frequent, and the need to identify a safe alternative drug is a common problem in clinical practice." | 2.71 | [The selective cyclooxygenase-2 inhibitor celecoxib is a safe alternative in patients with pseudo-allergic reactions to nonsteroidal anti-inflammatory drugs]. ( Ahlbach, S; Boehncke, WH; Kaufmann, R; Usadel, KH, 2003) |
| "Controlled oral challenge with nonsteroidal anti-inflammatory drugs (NSAIDs) is the only definite way to detect safe NSAIDs in patients with NSAID-induced anaphylactoid reactions." | 2.71 | Safety of the new selective cyclooxygenase type 2 inhibitors rofecoxib and celecoxib in patients with anaphylactoid reactions to nonsteroidal anti-inflammatory drugs. ( Conde, J; Delgado, J; Florido, JF; López-Pascual, E; Nieto, MA; Ortega, N; Quiralte, J; Sáenz de San Pedro, B, 2004) |
| "We evaluated the tolerability of CE in a group of patients with documented history of adverse cutaneous reactions to P and N associated or not to classic NSAIDs." | 2.71 | Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs. ( D'Amato, G; D'Amato, M; Liccardi, G; Piccolo, A; Piscitelli, E; Salzillo, A; Senna, G, 2005) |
| " Thus, we conclude that CE is a reasonably safe alternative which can be used in subjects who do not tolerate P." | 2.71 | Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and other non-steroidal anti-inflammatory drugs. ( Cazzola, M; D'Amato, G; D'Amato, M; De Giglio, C; Liccardi, G; Manfredi, D; Piscitelli, E, 2005) |
| "Forty-nine patients with a history of respiratory hypersensitivity reactions to NSAIDs (N-ERD) who underwent a drug challenge test with celecoxib, nimesulide, meloxicam, and paracetamol between January 2021-April 2022 were retrospectively evaluated." | 1.72 | Which non-steroidal anti-inflammatory drug (NSAID) is safer in patients with Non-steroids Exacerbated Respiratory Disease (N-ERD)? A single-center retrospective study. ( Çakmak, ME, 2022) |
| "Celecoxib itself seems to be a valuable alternative drug in NSAID-sensitive patients." | 1.31 | Positive patch test reactions to celecoxib may be due to irritation and do not correlate with the results of oral provocation. ( Boehncke, WH; Kaufmann, R; Kleinhans, M; Linzbach, L; Zedlitz, S, 2002) |
| "Erythema multiforme is an acute inflammatory skin reaction that often is caused by drugs, especially sulfonamides and their derivatives." | 1.31 | Celecoxib-induced erythema multiforme with glyburide cross-reactivity. ( Egge, JA; Ernst, EJ, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.33) | 18.2507 |
| 2000's | 32 (74.42) | 29.6817 |
| 2010's | 8 (18.60) | 24.3611 |
| 2020's | 2 (4.65) | 2.80 |
| Authors | Studies |
|---|---|
| Çakmak, ME | 1 |
| Romero-Sánchez, L | 1 |
| López-Freire, S | 1 |
| González-Fernández, T | 1 |
| Méndez-Brea, P | 1 |
| Jin, Y | 1 |
| Regev, A | 1 |
| Kam, J | 1 |
| Phipps, K | 1 |
| Smith, C | 1 |
| Henck, J | 1 |
| Campanale, K | 1 |
| Hu, L | 1 |
| Hall, DG | 1 |
| Yang, XY | 1 |
| Nakano, M | 1 |
| McNearney, TA | 1 |
| Uetrecht, J | 1 |
| Landschulz, W | 1 |
| Schaller, A | 1 |
| Metz-Favre, C | 1 |
| Guenard-Bilbaut, L | 1 |
| De Blay, F | 1 |
| Larrey, E | 1 |
| Patouraux, S | 1 |
| Spreux, A | 1 |
| Canivet, CM | 1 |
| Piche, T | 1 |
| Tran, A | 1 |
| Anty, R | 1 |
| Morales, DR | 1 |
| Lipworth, BJ | 1 |
| Guthrie, B | 1 |
| Jackson, C | 1 |
| Donnan, PT | 1 |
| Santiago, VH | 1 |
| Caimmi, SM | 1 |
| Manca, E | 1 |
| Caimmi, D | 1 |
| Marseglia, GL | 1 |
| Demoly, P | 1 |
| Muñoz-Cano, R | 1 |
| Bartra, J | 1 |
| Vennera, MC | 1 |
| Valero, A | 1 |
| Picado, C | 1 |
| Cimbollek, S | 1 |
| Quiralte, J | 2 |
| Avila, R | 1 |
| Morito, H | 1 |
| Ogawa, K | 1 |
| Kobayashi, N | 1 |
| Fukumoto, T | 1 |
| Asada, H | 1 |
| Kasemsarn, P | 1 |
| Kulthanan, K | 1 |
| Tuchinda, P | 1 |
| Dhana, N | 1 |
| Jongjarearnprasert, K | 1 |
| Burbach, GJ | 1 |
| Vajkoczy, P | 1 |
| Zuberbier, T | 1 |
| Lander, SA | 1 |
| Wallace, DJ | 1 |
| Weisman, MH | 1 |
| Woessner, KM | 1 |
| Simon, RA | 1 |
| Stevenson, DD | 1 |
| García-Rodríguez, RM | 1 |
| Hinojosa, M | 1 |
| Camacho-Garrido, E | 1 |
| Berges Gimeno, P | 1 |
| Martín García, C | 1 |
| Kleinhans, M | 1 |
| Linzbach, L | 1 |
| Zedlitz, S | 1 |
| Kaufmann, R | 2 |
| Boehncke, WH | 2 |
| Shapiro, LE | 1 |
| Knowles, SR | 1 |
| Weber, E | 1 |
| Neuman, MG | 1 |
| Shear, NH | 2 |
| Ahlbach, S | 1 |
| Usadel, KH | 1 |
| Gyllfors, P | 1 |
| Bochenek, G | 1 |
| Overholt, J | 1 |
| Drupka, D | 1 |
| Kumlin, M | 1 |
| Sheller, J | 1 |
| Nizankowska, E | 1 |
| Isakson, PC | 1 |
| Mejza, F | 1 |
| Lefkowith, JB | 1 |
| Dahlén, SE | 1 |
| Szczeklik, A | 3 |
| Murray, JJ | 1 |
| Dahlén, B | 1 |
| Kruse, R | 1 |
| Ruzicka, T | 1 |
| Grewe, M | 1 |
| Verrico, MM | 1 |
| Weber, RJ | 1 |
| McKaveney, TP | 1 |
| Ansani, NT | 1 |
| Towers, AL | 1 |
| West, PM | 1 |
| Fernández, C | 1 |
| Senna, G | 2 |
| Bilò, MB | 1 |
| Antonicelli, L | 1 |
| Schiappoli, M | 1 |
| Crivellaro, MA | 1 |
| Bonadonna, P | 1 |
| Dama, AR | 1 |
| Delgado, J | 1 |
| Sáenz de San Pedro, B | 1 |
| López-Pascual, E | 1 |
| Nieto, MA | 1 |
| Ortega, N | 2 |
| Florido, JF | 1 |
| Conde, J | 1 |
| Liccardi, G | 3 |
| D'Amato, G | 3 |
| Canonica, GW | 1 |
| Lobefalo, G | 1 |
| Noschese, P | 1 |
| Piccolo, A | 2 |
| Salzillo, A | 2 |
| Passalacqua, G | 1 |
| Piscitelli, E | 2 |
| D'Amato, M | 2 |
| Celik, G | 1 |
| Paşaoğlu, G | 1 |
| Bavbek, S | 1 |
| Abadoğlu, O | 1 |
| Dursun, B | 1 |
| Mungan, D | 1 |
| Misirligil, Z | 1 |
| Viola, M | 1 |
| Quaratino, D | 1 |
| Gaeta, F | 1 |
| Caringi, M | 1 |
| Valluzzi, R | 1 |
| Caruso, C | 1 |
| Volpetti, S | 1 |
| Romano, A | 1 |
| Sánchez-Borges, M | 1 |
| Caballero-Fonseca, F | 1 |
| Capriles-Hulett, A | 1 |
| Cazzola, M | 1 |
| De Giglio, C | 1 |
| Manfredi, D | 1 |
| Wyplosz, B | 1 |
| Vautier, S | 1 |
| Lillo-Le Louët, A | 1 |
| Capron, L | 1 |
| Mastalerz, L | 2 |
| Sanak, M | 2 |
| Gawlewicz, A | 1 |
| Gielicz, A | 2 |
| Faber, J | 1 |
| Ch'ng, A | 1 |
| Lowe, M | 1 |
| Figueroa, J | 1 |
| Almeida, L | 1 |
| Blanco, C | 1 |
| Castillo, R | 1 |
| Roll, A | 1 |
| Wüthrich, B | 1 |
| Schmid-Grendelmeier, P | 1 |
| Hofbauer, G | 1 |
| Ballmer-Weber, BK | 1 |
| Smith, WB | 1 |
| Mullins, RJ | 1 |
| Gawlewicz-Mroczka, A | 1 |
| Cmiel, A | 1 |
| Patterson, R | 1 |
| Bello, AE | 1 |
| Lefkowith, J | 1 |
| Knowles, S | 1 |
| Shapiro, L | 1 |
| Jones, DB | 1 |
| Wiholm, BE | 1 |
| Ernst, EJ | 1 |
| Egge, JA | 1 |
5 reviews available for celecoxib and Drug Hypersensitivity
| Article | Year |
|---|---|
Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Bronchial Spasm; Celecoxib; Clinical Trial | 2014 |
Celecoxib for systemic lupus erythematosus: case series and literature review of the use of NSAIDs in SLE.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Celecoxib; Cyclooxygenas | 2002 |
Safety of COX-2 inhibitors in asthma patients with aspirin hypersensitivity.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Celecoxib; Cyclooxygenase 2; Drug Hypersen | 2003 |
Immunologic tolerability profile of celecoxib.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Clinical Trials as Topic; Cross Reactions; Cyclo | 1999 |
Should celecoxib be contraindicated in patients who are allergic to sulfonamides? Revisiting the meaning of 'sulfa' allergy.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cross Reactions; Drug Hyp | 2001 |
16 trials available for celecoxib and Drug Hypersensitivity
| Article | Year |
|---|---|
Dose-dependent acute liver injury with hypersensitivity features in humans due to a novel microsomal prostaglandin E synthase 1 inhibitor.
Topics: Administration, Oral; Adult; Area Under Curve; Celecoxib; Chemical and Drug Induced Liver Injury; Cy | 2018 |
The safety of celecoxib in patients with aspirin-sensitive asthma.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Celecoxib; Cyclooxygenase Inhibitors; Dose | 2002 |
Safety of celecoxib in individuals allergic to sulfonamide: a pilot study.
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Celecoxib; Cross Reactions; Cyclooxygenase | 2003 |
[The selective cyclooxygenase-2 inhibitor celecoxib is a safe alternative in patients with pseudo-allergic reactions to nonsteroidal anti-inflammatory drugs].
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase I | 2003 |
Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Celecoxib; Cross-Over Studies | 2003 |
Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.
Topics: Adolescent; Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Celec | 2004 |
Safety of the new selective cyclooxygenase type 2 inhibitors rofecoxib and celecoxib in patients with anaphylactoid reactions to nonsteroidal anti-inflammatory drugs.
Topics: Adult; Aged; Anaphylaxis; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Celecoxib; Cyclooxyge | 2004 |
Safety of celecoxib in patients with adverse reactions to nimesulide.
Topics: Adolescent; Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Drug Hypers | 2005 |
Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs.
Topics: Acetaminophen; Adolescent; Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Celecox | 2005 |
Tolerability of selective cyclooxygenase inhibitor, celecoxib, in patients with analgesic intolerance.
Topics: Adult; Anaphylaxis; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bronchial Spasm; Celecoxib; Cy | 2005 |
Celecoxib tolerability in patients with hypersensitivity (mainly cutaneous reactions) to nonsteroidal anti-inflammatory drugs.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibito | 2005 |
Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema.
Topics: Adolescent; Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygen | 2005 |
Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and other non-steroidal anti-inflammatory drugs.
Topics: Acetaminophen; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase | 2005 |
Sulfonamide allergy without cross-reactivity to celecoxib.
Topics: Adolescent; Adult; Bronchial Provocation Tests; Celecoxib; Cross Reactions; Drug Hypersensitivity; F | 2007 |
Tolerance to celecoxib in patients with a history of adverse reactions to nonsteroidal anti-inflammatory drugs.
Topics: Acetaminophen; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Ster | 2006 |
Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity.
Topics: Adult; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Case-Control | 2008 |
22 other studies available for celecoxib and Drug Hypersensitivity
| Article | Year |
|---|---|
Which non-steroidal anti-inflammatory drug (NSAID) is safer in patients with Non-steroids Exacerbated Respiratory Disease (N-ERD)? A single-center retrospective study.
Topics: Acetaminophen; Adult; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitor | 2022 |
[Selective cyclooxygenase-2 inhibitor hypersensitivity].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Hypersen | 2023 |
[Is celecoxib a safe alternative for the Fernand Widal syndrome?]
Topics: Adult; Aged; Aspirin; Asthma; Case-Control Studies; Celecoxib; Drug Hypersensitivity; Female; France | 2018 |
Fatal cholestatic hepatitis after a single dose of celecoxib.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chemical and Drug Induced Liver Injury; Ch | 2019 |
NSAID hypersensitivity in twins.
Topics: Adolescent; Allergens; Anti-Inflammatory Agents, Non-Steroidal; Autoantibodies; Celecoxib; Child; Ch | 2014 |
Asthmatic reaction induced by celecoxib in a patient with aspirin-induced asthma.
Topics: Adult; Aspirin; Asthma; Bronchial Spasm; Celecoxib; Cyclooxygenase Inhibitors; Drug Hypersensitivity | 2009 |
COX-2 inhibitors in patients with sensitivity to nonselective NSAIDs.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug E | 2009 |
Drug-induced hypersensitivity syndrome followed by persistent arthritis.
Topics: Anti-Arrhythmia Agents; Arthralgia; Arthritis; Celecoxib; Chronic Disease; Cyclooxygenase 2 Inhibito | 2012 |
Cutaneous reactions to non-steroidal anti-inflammatory drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Cel | 2011 |
Celecoxib desensitization: continued temozolomide/celecoxib chemotherapy after a celecoxib-induced hypersensitivity reaction.
Topics: Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Celecoxib; Cyclooxygenase 2 Inhibitors; Dacar | 2012 |
Celecoxib, safe in NSAID intolerance.
Topics: Administration, Oral; Adult; Aged; Angioedema; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; C | 2002 |
Positive patch test reactions to celecoxib may be due to irritation and do not correlate with the results of oral provocation.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; C | 2002 |
Intolerance reactions due to the selective cyclooxygenase type II inhibitors rofecoxib and celecoxib. Results of oral provocation tests in patients with NSAID hypersensitivity.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; Drug Hypersensitivity | 2003 |
Adverse Drug Events Involving COX-2 Inhibitors.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Anti-Inflammatory Agents, N | 2003 |
Tolerance of diclofenac after hypersensitivity to celecoxib and to nabumetone.
Topics: Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Butanones; Celecoxib; Cyclooxygenase Inh | 2006 |
Different eicosanoid profile of the hypersensitivity reactions triggered by aspirin and celecoxib in a patient with sinusitis, asthma, and urticaria.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Celecoxib; Drug Hypersensitivity; E | 2006 |
Celecoxib allergies and cross-reactivity.
Topics: Aged; Analgesics; Anti-Bacterial Agents; Celecoxib; Drug Hypersensitivity; Female; Humans; Pyrazoles | 2006 |
No proof of cross-reactivity between celecoxib and antibiotic sulfonamides.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cross Reactions; Drug Hyp | 2007 |
COX-2 inhibitors.
Topics: Aged; Celecoxib; Cyclooxygenase Inhibitors; Drug Hypersensitivity; Female; Humans; Middle Aged; Pyra | 2001 |
Cutaneous drug reaction case reports: from the world literature.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Aged; Bupropion; Celecoxib; Chlorquinaldol; Cytarabi | 2002 |
Should celecoxib be contraindicated in patients who are allergic to sulfonamides?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Contraindications; Drug Hypersensitivity; Humans | 2002 |
Celecoxib-induced erythema multiforme with glyburide cross-reactivity.
Topics: Celecoxib; Cross Reactions; Cyclooxygenase Inhibitors; Drug Hypersensitivity; Drug Interactions; Ery | 2002 |